NO172489C - Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater - Google Patents
Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivaterInfo
- Publication number
- NO172489C NO172489C NO883392A NO883392A NO172489C NO 172489 C NO172489 C NO 172489C NO 883392 A NO883392 A NO 883392A NO 883392 A NO883392 A NO 883392A NO 172489 C NO172489 C NO 172489C
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- therapeutic active
- analogy procedure
- imidazold
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D233/84—Sulfur atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/36—Sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/36—Sulfur atom
- C07D473/38—Sulfur atom attached in position 6
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT21538/87A IT1222412B (it) | 1987-07-31 | 1987-07-31 | Tiometil e sulfinil metil derivati ad azione antisecretiva acida gastrica,loro procedimento di preparazione e composizioni farmaceutiche che li contengono |
Publications (4)
Publication Number | Publication Date |
---|---|
NO883392D0 NO883392D0 (no) | 1988-07-29 |
NO883392L NO883392L (no) | 1989-02-01 |
NO172489B NO172489B (no) | 1993-04-19 |
NO172489C true NO172489C (no) | 1993-07-28 |
Family
ID=11183290
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO883392A NO172489C (no) | 1987-07-31 | 1988-07-29 | Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater |
Country Status (13)
Country | Link |
---|---|
US (2) | US5049566A (no) |
EP (1) | EP0301422A3 (no) |
JP (1) | JPS6463575A (no) |
KR (1) | KR890002115A (no) |
AU (1) | AU615933B2 (no) |
DK (1) | DK427288A (no) |
FI (1) | FI883511A (no) |
HU (1) | HU201058B (no) |
IT (1) | IT1222412B (no) |
NO (1) | NO172489C (no) |
NZ (1) | NZ225629A (no) |
PT (1) | PT88141A (no) |
ZA (1) | ZA885585B (no) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0643426B2 (ja) * | 1986-07-25 | 1994-06-08 | 東京田辺製薬株式会社 | イミダゾ〔4,5−b〕ピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤 |
DE3639926A1 (de) * | 1986-11-22 | 1988-06-01 | Hoechst Ag | Substituierte thienoimidazoltoluidin-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer |
AU622866B2 (en) * | 1987-07-21 | 1992-04-30 | Hoechst Aktiengesellschaft | Substituted thienoimidazole derivatives, processes for their preparation, pharmaceutical formulations containing them and their use as gastric acid secretion inhibitors |
IT1222412B (it) * | 1987-07-31 | 1990-09-05 | Chiesi Farma Spa | Tiometil e sulfinil metil derivati ad azione antisecretiva acida gastrica,loro procedimento di preparazione e composizioni farmaceutiche che li contengono |
JPS6440467A (en) * | 1987-08-04 | 1989-02-10 | Hisamitsu Pharmaceutical Co | Novel substituted diphenylimidazole derivative |
JP2582406B2 (ja) * | 1988-04-11 | 1997-02-19 | 日清製粉株式会社 | 新規なキノキサリン誘導体及びそれを含有する坑潰瘍剤 |
JP2614756B2 (ja) * | 1988-08-10 | 1997-05-28 | 日本ケミファ株式会社 | イミダゾール誘導体およびその製造法ならびにこれを含有する抗潰瘍剤 |
JP2679745B2 (ja) * | 1989-06-29 | 1997-11-19 | 明治製菓株式会社 | アゾール誘導体及びそれらを有効成分とする抗潰瘍剤 |
ATE102610T1 (de) * | 1989-08-10 | 1994-03-15 | Nippon Chemiphar Co | Imidazolderivate, verfahren zu deren herstellung und diese enthaltende antiulkusmittel. |
JP2933739B2 (ja) * | 1990-04-09 | 1999-08-16 | 明治製菓株式会社 | チアゾールまたはイミダゾール誘導体および抗潰瘍剤 |
JPH0770083A (ja) * | 1993-07-05 | 1995-03-14 | Nippon Chemiphar Co Ltd | イミダゾール誘導体を有効成分とする血圧降下剤 |
JP3046924B2 (ja) * | 1995-03-27 | 2000-05-29 | 株式会社アラクス | イミダゾリン誘導体又はそれらの可能な互変異性体及びそれらの製造方法並びにそれらを有効成分とする創傷治療薬 |
FR2751649B1 (fr) * | 1996-07-26 | 1998-08-28 | Adir | Nouveaux derives de benzimidazole, de benzoxazole et de benzothiazole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US6159968A (en) * | 1998-01-15 | 2000-12-12 | University Of Cincinnati | Activation of chloride channels for correction of defective chloride transport |
JP5911476B2 (ja) * | 2010-05-26 | 2016-04-27 | スノビオン プハルマセウトイカルス インコーポレイテッド | ヘテロアリール化合物及びその使用方法 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2580475A (en) * | 1947-10-30 | 1952-01-01 | Schering Corp | Imidazolinylalkyl ethers of pyridylcarbinols |
US3238207A (en) * | 1960-03-01 | 1966-03-01 | Burroughs Wellcome Co | 6-oxyorganopurines and method of preparing them |
US3714179A (en) * | 1970-09-08 | 1973-01-30 | Searle & Co | 1-alkyl-2-furfurylthioimidazoles and congeners |
GB2038825B (en) * | 1978-12-16 | 1983-02-09 | Wyeth John & Brother Ltd | Heterocyclic compounds substituted by heterocyclyl-alkyl-thio groups |
US4330552A (en) * | 1980-11-06 | 1982-05-18 | E. I. Du Pont De Nemours And Company | Antiinflammatory 4,5-diaryl-2-arylthioimidazoles |
AU4640985A (en) * | 1984-08-31 | 1986-03-06 | Nippon Chemiphar Co. Ltd. | Benzimidazole derivatives |
EP0187977B1 (en) * | 1984-12-18 | 1990-08-29 | Otsuka Pharmaceutical Co., Ltd. | Tetrahydroquinoline derivatives, process for preparing the same and anti-peptic ulcer compositions containg the same |
FI861772A (fi) * | 1985-05-07 | 1986-11-08 | Chemie Linz Ag | Nya tieno(2,3-d)imidazolderivat och foerfarande for deras framstaellning. |
AR243167A1 (es) * | 1985-08-24 | 1993-07-30 | Hoechst Ag | Procedimiento para la preparacion de toluidinas sustituidas. |
KR950001015B1 (ko) * | 1986-01-10 | 1995-02-07 | 닛뽕 케미화 가부시끼가이샤 | 술폭시드 유도체의 제조방법 |
ES2032394T3 (es) * | 1986-02-20 | 1993-02-16 | Hoechst Aktiengesellschaft | Procedimiento para preparar derivados de tienoimidazol sustituidos. |
WO1987005296A1 (en) * | 1986-03-07 | 1987-09-11 | Pfizer Inc. | 2-[(2-pyridyl)methylsulfinyl]thienoimidazoles and related compounds as antiulcer agents |
JPH0643426B2 (ja) * | 1986-07-25 | 1994-06-08 | 東京田辺製薬株式会社 | イミダゾ〔4,5−b〕ピリジン誘導体、その製造法及びそれを含有する抗潰瘍剤 |
DE3639926A1 (de) * | 1986-11-22 | 1988-06-01 | Hoechst Ag | Substituierte thienoimidazoltoluidin-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer |
DE3723327A1 (de) * | 1987-07-15 | 1989-02-02 | Hoechst Ag | Substituierte thienoimidazol-derivate, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung als magensaeuresekretionshemmer, magenschutzmittel sowie als medikament gegen intestinale entzuendungen |
IT1222412B (it) * | 1987-07-31 | 1990-09-05 | Chiesi Farma Spa | Tiometil e sulfinil metil derivati ad azione antisecretiva acida gastrica,loro procedimento di preparazione e composizioni farmaceutiche che li contengono |
-
1987
- 1987-07-31 IT IT21538/87A patent/IT1222412B/it active
-
1988
- 1988-07-22 EP EP88111813A patent/EP0301422A3/en not_active Ceased
- 1988-07-26 FI FI883511A patent/FI883511A/fi not_active Application Discontinuation
- 1988-07-28 JP JP63189533A patent/JPS6463575A/ja active Pending
- 1988-07-29 NO NO883392A patent/NO172489C/no unknown
- 1988-07-29 NZ NZ225629A patent/NZ225629A/xx unknown
- 1988-07-29 PT PT88141A patent/PT88141A/pt unknown
- 1988-07-29 DK DK427288A patent/DK427288A/da not_active Application Discontinuation
- 1988-07-29 KR KR1019880009620A patent/KR890002115A/ko not_active Application Discontinuation
- 1988-07-29 HU HU884043A patent/HU201058B/hu not_active IP Right Cessation
- 1988-07-29 ZA ZA885585A patent/ZA885585B/xx unknown
- 1988-08-01 AU AU20228/88A patent/AU615933B2/en not_active Ceased
-
1990
- 1990-03-14 US US07/493,957 patent/US5049566A/en not_active Expired - Fee Related
- 1990-03-14 US US07/494,864 patent/US5066652A/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
US5066652A (en) | 1991-11-19 |
AU2022888A (en) | 1989-02-02 |
FI883511A0 (fi) | 1988-07-26 |
IT8721538A0 (it) | 1987-07-31 |
NZ225629A (en) | 1991-01-29 |
EP0301422A3 (en) | 1990-03-28 |
KR890002115A (ko) | 1989-04-07 |
EP0301422A2 (en) | 1989-02-01 |
ZA885585B (en) | 1989-04-26 |
NO883392L (no) | 1989-02-01 |
NO883392D0 (no) | 1988-07-29 |
PT88141A (pt) | 1989-06-30 |
JPS6463575A (en) | 1989-03-09 |
HUT47930A (en) | 1989-04-28 |
HU201058B (en) | 1990-09-28 |
DK427288D0 (da) | 1988-07-29 |
IT1222412B (it) | 1990-09-05 |
FI883511A (fi) | 1989-02-01 |
NO172489B (no) | 1993-04-19 |
AU615933B2 (en) | 1991-10-17 |
DK427288A (da) | 1989-02-01 |
US5049566A (en) | 1991-09-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO171506C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive adenosin-derivater | |
NO168770C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
NO172801C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater | |
NO170727C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzopyran-derivater | |
NO170629C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater | |
NO170726C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive quinolinderivater | |
NO159089C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive glutarimidderivater. | |
NO168174C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive triazolforbindelser | |
NO169438C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrazolforbindelser | |
NO168355C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzimidazolderivater | |
NO165841C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive heteroaryl-3-okso-propannitril-derivater. | |
NO171507C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive nukleotidderivater | |
NO172489C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazolderivater | |
NO168299C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater | |
NO172539C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive indolpiperidin-forbindelser | |
NO170021C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 3-propenylcefem-derivater | |
NO170582C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive aryl-piperazinyl-alkylenfenyl-heterocykliske forbindelser | |
NO173185C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoxalinforbindelser | |
NO168037C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive purin-derivater. | |
NO169069C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-alkoksy-2-aminopropylaminderivater | |
NO169007C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive uridinderivater | |
NO172643C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzopyranolderivater | |
NO173061C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 2-benzotiazoliner | |
NO161313C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive fluorallylaminderivater. | |
NO171501C (no) | Analogifremgangsmaate ved fremstilling av terapeutisk aktive 2-metoksymetylpenem-derivater |